United States Patent 11,198,697: A Detailed Analysis
Overview of the Patent
The United States Patent 11,198,697, titled "(3S,4R)-3-[(3-{4-[(2,3-Dimethyl-2H-1,2,4-triazol-3-yl)sulfanyl]phenyl}pyridin-2-yl)amino]piperidine-1-carboxylic acid (5-methoxy-2-[(4-methoxyphenyl)methyl]-1H-indol-3-yl)amide and Methods of Use Thereof," is a complex patent that encompasses various aspects of pharmaceutical chemistry and drug development.
Scope of Protection
Subject Matter
The patent protects a specific chemical compound and its methods of use, particularly in the context of pharmaceutical applications. The compound in question is a complex organic molecule designed for therapeutic purposes, likely targeting specific biological pathways or diseases[4].
Claim Types
The patent includes various types of claims, such as:
- Composition of Matter Claims: These claims cover the specific chemical structure of the compound.
- Method of Use Claims: These claims describe the ways in which the compound can be used, such as in the treatment of certain diseases or conditions.
- Process Claims: These claims detail the methods for preparing the compound.
Claim Drafting Strategies
Specificity and Breadth
The claims in this patent are drafted to balance specificity and breadth. The composition of matter claims is highly specific, detailing the exact chemical structure of the compound. This specificity helps in ensuring that the patent covers the exact invention without overly broad claims that might be challenged for lack of novelty or non-obviousness[4].
Dependent Claims
The patent likely includes dependent claims that build upon the independent claims, providing additional limitations and details. These dependent claims help in narrowing down the scope of protection and can offer additional layers of protection against infringement.
Patent Landscape
Prior Art and Citations
The patent cites numerous prior art references, including earlier patents and publications related to similar compounds and methods. This extensive citation list indicates a thorough review of existing knowledge in the field to ensure the novelty and non-obviousness of the invention[4].
Geographical and Organizational Context
While the patent itself does not provide geographical or organizational context, it is part of a broader landscape of pharmaceutical patents. Companies and research institutions involved in drug development often have extensive patent portfolios to protect their innovations.
Regulatory Considerations
Patent Term Restoration
The patent may be subject to patent term restoration under the Patent Term Restoration Act, which allows for the extension of a patent term to compensate for delays in the regulatory approval process. This is particularly relevant for pharmaceutical patents, where regulatory review periods can be lengthy[2].
Terminal Disclaimer
The patent includes a terminal disclaimer, which is a statement that the patent term will not extend beyond a certain date. This is often used to avoid issues related to double patenting, ensuring that the inventor does not secure multiple patents for the same invention that expire at different times[4].
Technological and Scientific Context
Chemical Synthesis
The patent details the chemical synthesis of the compound, which involves complex organic chemistry techniques. This includes specific reactions, reagents, and conditions necessary for the preparation of the compound[4].
Therapeutic Applications
The compound is likely intended for therapeutic use, and the patent may include data or references to clinical trials or preclinical studies that support its efficacy and safety.
Key Takeaways
- Specificity in Claims: The patent's claims are highly specific to ensure strong protection for the exact chemical compound and its methods of use.
- Extensive Prior Art: The patent cites a wide range of prior art, indicating a thorough review of existing knowledge in the field.
- Regulatory Compliance: The patent is subject to regulatory considerations such as patent term restoration and terminal disclaimers.
- Therapeutic Focus: The compound is designed for therapeutic applications, with detailed methods of synthesis and potential use in treating specific diseases.
FAQs
1. What is the main subject matter protected by United States Patent 11,198,697?
The main subject matter protected is a specific chemical compound and its methods of use, particularly in pharmaceutical applications.
2. How are the claims in this patent drafted?
The claims are drafted to balance specificity and breadth, with composition of matter claims being highly specific and method of use claims detailing the therapeutic applications.
3. What is the significance of the terminal disclaimer in this patent?
The terminal disclaimer ensures that the patent term does not extend beyond a certain date, avoiding issues related to double patenting.
4. How does the Patent Term Restoration Act apply to this patent?
The patent may be eligible for patent term restoration to compensate for delays in the regulatory approval process, which is common for pharmaceutical patents.
5. What is the importance of prior art citations in this patent?
Prior art citations are crucial to establish the novelty and non-obviousness of the invention, demonstrating a thorough review of existing knowledge in the field.
Cited Sources
- United States Court of Appeals for the Federal Circuit. ABBVIE INC. v. KENNEDY INST. OF RHEUMATOLOGY, 2014.
- FDA. Frequently Asked Questions on the Patent Term Restoration Program, 2020.
- Stanford Law School. Quantum Leap: Decoding Quantum Computing Innovation, 2023.
- United States Patent and Trademark Office. United States Patent 11,198,697 B1, 2021.
- PubChem. PROCESSES FOR THE PREPARATION OF (3S,4R)-3-[(3-{4-[(2,3-Dimethyl-2H-1,2,4-triazol-3-yl)sulfanyl]phenyl}pyridin-2-yl)amino]piperidine-1-carboxylic acid (5-methoxy-2-[(4-methoxyphenyl)methyl]-1H-indol-3-yl)amide and Methods of Use Thereof, 2018.
